News

Palantir Has a Hand in NIH’s Most Ambitious Health Initiative

By Julia Métraux, Mother Jones [cites CGS' Katie Hasson] | 07.07.2026

During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...

U.S. Federal

The Measured Listener

By Daniel Shanahan, Los Angeles Review of Books | 05.31.2026

This is the 15th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. You can read the first part here. The series...

U.S. States

These companies help parents try to pick their babies' traits. Experts are wary

By Rob Stein, NPR [cites CGS' Katie Hasson] | 05.06.2026

Justin Schleede reaches onto a black lab bench to pick up a tray of small plastic tubes.

"These are saliva...

Genetic Selection

The start-ups dreaming of creating genetically modified babies

By Alexandre Piquard, Le Monde [cites CGS' Katie Hasson] | 05.22.2026

"If proven to be safe, we believe preventive gene editing could be one of the most important health technologies of...

U.S. Federal

Stem cell rule riles critics

By Sacramento Bee, Sacramento Bee | 07.07.2005

SAN FRANCISCO - Scientists from around the country charged with proposing medical and ethical standards for California's stem cell research...

Stem Cells

Should Journals Publish Industry-Funded Bioethics Articles?

By Carl Elliott, The Lancet | 07.06.2005
North American bioethics has a growing credibility problem. As the influence of bioethics has grown, so has the willingness of...
Biotech & Pharma

California Stem-Cell Agency Gets Off to Inauspicious Start

By David P. Hamilton, The Wall Street Journal | 07.05.2005
AS POLITICIANS in Washington tussle over a bill that could expand federal funding for embryonic stem-cell research, California's newly minted...
Biotech & Pharma

One Step Forward, Two Steps Back

By Osagie Obasogie, San Francisco Chronicle | 07.05.2005

NitroMed's BiDil recently received FDA approval as the first drug targeted exclusively for a racial group -- African Americans with...

Racial Justice

Stem cell group ready to disburse funds: Institute, critics near agreement on conflicts, meetings

By Carl T. Hall, San Francisco Chronicle | 07.02.2005
California's $3 billion experiment in state-financed stem cell research has arrived at a critical turning point.

Officials leading the California...
Stem Cells

Opinion: Oversight is critical for confidence in stem-cell research

By Kathay Feng, Steven Blackledge, San Francisco Chronicle | 06.30.2005
All it would take is one major scandal, some sign of mismanagement or ethical lapse, and Californians' trust -- and...
Patents & Other IP

Have we been oversold the stem cell dream?

By Roger Highfield, The Telegraph (UK) | 06.29.2005
They offer the solution for every human woe. The infertile can use them to grow eggs and sperm. Dementia, heart...
Media Coverage

Test reveals gender early in pregnancy: Ethicists fear use in sex selection

By Boston Globe, Boston Globe | 06.27.2005

First came the home pregnancy test. Now here comes the home gender test.

A new blood test being marketed to...

Technologies